Opinion: Infectious disease expert: The mysterious pneumonia in Russia deserves attention, not panic
Chill out about reports about plague in Siberia, writes infectious disease doctor Krutika Kuppalli.
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 721 articles · page 5 of 21 · fetched about 1 hour ago
STAT+: AstraZeneca opens new Boston site
AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled…
Read at source →
STAT+: Are stem cell treatments about to have their day?
Stem cells might be the next peptides, and how Trump's $90 checks will play out after the election.
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
What are hospital longevity programs, and what can they tell you about your health?
What can hospital longevity clinics can tell you about your health? STAT's Sarah Todd went to one to find out.
Read at source →
STAT+: FDA spells out 2027 AI guidance plans
In this edition of STAT Health Tech: New AI guidances expected from the the FDA in 2027, Utah expanding its AI sandbox,…
Read at source →
STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more
The Trump administration is advancing the first government-funded clinical trials of the psychedelic drug ibogaine to…
Read at source →
Deciding when to get your flu shot? Consider these factors
When’s the best time to be vaccinated? Here are some thoughts that may help you make your decision.
Read at source →
In this hospital, pulse oximeters went from overestimating to underestimating blood oxygen. Why?
Researchers found pulse oximeters went from overestimating blood oxygen levels to underestimating them; inaccuracies…
Read at source →
Opinion: I’m a doctor. Here’s what I want the public to know about AI tools and health care costs
“We can document honestly and still wind up inflating hospital bills,” writes a frustrated doctor.
Read at source →
Opinion: Why the FDA should not approve an ineffective multicancer screening test
“Telling more people they have cancer is not progress; progress is having fewer people die from cancer,” H. Gilbert…
Read at source →
STAT+: Can you live longer for $5,500? Longevity clinics are the buzzy new trend at nonprofit hospitals
Longevity clinics promise personalized health advice and cutting-edge tests. Now major hospitals are entering the…
Read at source →
STAT+: Judges skewer HHS arguments in hearing over Medicare Advantage audits lawsuit
Federal judges pushed back against the government's arguments in a Medicare Advantage case.
Read at source →
STAT+: Nobel-winning optogenetics research has led to experimental treatments for blindness and Alzheimer’s
Optogenetics is now the foundational way through which we are able to understand how the brain works
Read at source →
STAT+: New Trump regulations would clean up health care pricing disclosures
The Trump administration is continuing its effort to bring more transparency to the cost of health care.
Read at source →
STAT+: Prices, prices, prices
Why is health insurance so expensive? Read the latest stort in STAT's "Out of Pocket, Out of Reach" series to find out.
Read at source →
STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
Utah plans to allow an AI product to evaluate patients and write new drug prescriptions without prior human review.
Read at source →
STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
Eli Lilly’s Jaypirca has won FDA approval for previously untreated chronic lymphocytic leukemia and small lymphocytic…
Read at source →STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more
Vaxcyte said its pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up a competition…
Read at source →
STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market
Vaxcyte said its experimental pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up…
Read at source →
Could we one day vaccinate against every cancer?
What science says so far about which cancers can be beat by vaccines — and which will require more creative approaches.
Read at source →
2026 Nobel Prize in Medicine awarded for brain research tool called optogenetics
Karl Deisseroth, Peter Hegemann, and Georg Nagel are the joint recipients of the 2026 Nobel Prize in Physiology or…
Read at source →
STAT+: Are stem cells the next peptides? These advocates think RFK Jr. could make it happen
Peptides gained legitimacy at the FDA after being embraced by MAHA. Advocates hope stem cell treatments will follow the…
Read at source →
Opinion: Will Claude ever win a Nobel Prize for medicine?
“Are we entering a world in which some (or all) Nobels will be awarded to Claude, ChatGPT, or their AI successors,…
Read at source →
STAT+: Divergent trial results on cancer vaccines have the field grappling with hard questions
A melanoma vaccine succeeded in a late-stage clinical trial. The question now is whether other cancer vaccines will…
Read at source →
Hospital and pharmaceutical prices are smothering America’s businesses
Workers and employers are drowning in their health insurance premiums. The reason for that deluge: the health care…
Read at source →
Opinion: Energy drinks’ new college sports partnerships make them more dangerous than ever
“In the absence of population-based evidence, the energy drink cabal is having an easy time of it,” writes Kent…
Read at source →
Trump announces $90 payments for seniors’ Medicare premium costs ahead of midterm elections
President Trump is promising more payments to voters just ahead of the Nov. 3 midterm elections — this time for…
Read at source →
NIH rolling out streamlined website to help public find information more easily
The redesign is intended to streamline what was a sprawling and fractured information ecosystem, requiring users to…
Read at source →
What it’s like to wait for the call from the Nobel Prize committee
Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer…
Read at source →
Access to addiction meds for young people has improved — but retention hasn’t
Only a small fraction of young people with opioid use disorder receive addiction medications, and few stay on them for…
Read at source →
An Ebola treatment center was burned down as the death toll in Congo passes 4,000
Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become…
Read at source →
STAT+: Lilly bypasses Australian pharmacies with DTC model
Eli Lilly is launching LillyDirect to deliver Mounjaro straight to Australian patients’ doors — and local doctors and…
Read at source →STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more
The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead…
Read at source →
How big is Pennsylvania’s measles outbreak?
News of a fifth measles death in Pennsylvania underscores a longstanding issue about the disease. The full scope of the…
Read at source →
STAT+: NIH awarded all its grant funding, but delayed and opaque decisions stymied researchers
The NIH continued reducing grants involving health disparities, race, and ethnicity but made little progress toward…
Read at source →
Opinion: The law has to catch up on orphan-designated drugs with multiple uses
The law has to catch up on the 340B drug discount program, writes a pharmacist.
Read at source →